These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17995584)

  • 1. Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome.
    Chan TM; Lin AW; Tang SC; Qian JQ; Lam MF; Ho YW; Tse KC; Chan KW; Lai KN; Tang CS
    Nephrology (Carlton); 2007 Dec; 12(6):576-81. PubMed ID: 17995584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study.
    Senthil Nayagam L; Ganguli A; Rathi M; Kohli HS; Gupta KL; Joshi K; Sakhuja V; Jha V
    Nephrol Dial Transplant; 2008 Jun; 23(6):1926-30. PubMed ID: 17989103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome.
    Yap DY; Yu X; Chen XM; Lu F; Chen N; Li XW; Tang CS; Chan TM
    Nephrology (Carlton); 2012 May; 17(4):352-7. PubMed ID: 22295934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial.
    Dussol B; Morange S; Burtey S; Indreies M; Cassuto E; Mourad G; Villar E; Pouteil-Noble C; Karaaslan H; Sichez H; Lasseur C; Delmas Y; Nogier MB; Fathallah M; Loundou A; Mayor V; Berland Y
    Am J Kidney Dis; 2008 Oct; 52(4):699-705. PubMed ID: 18585835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
    Li X; Tian J; Wu J; He Q; Li H; Han F; Li Q; Chen Y; Ni Q; Chen J
    Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
    Bagga A; Hari P; Moudgil A; Jordan SC
    Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate Mofetil with Steroid, a Reasonable Alternative to Current First-line Therapy, for Idiopathic Membranous Nephropathy in Resource-constrained Settings: A Randomized, Open-label Study.
    Sharma M; Roy A; Doley PK; Pegu G
    J Assoc Physicians India; 2024 Jun; 72(6):15-19. PubMed ID: 38881128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
    Okada M; Sugimoto K; Yagi K; Yanagida H; Tabata N; Takemura T
    Pediatr Int; 2007 Dec; 49(6):933-7. PubMed ID: 18045300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mycophenolate mofetil in the treatment of primary nephrotic syndrome].
    Zhao M; Chen X; Chen Y; Liu Z; Liu Y; Lu F; Zhang Y; Wang H
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):528-31. PubMed ID: 11809115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A; Gupta A; Kalaivani M; Hari P; Dinda AK; Bagga A
    Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide.
    Branten AJ; du Buf-Vereijken PW; Vervloet M; Wetzels JF
    Am J Kidney Dis; 2007 Aug; 50(2):248-56. PubMed ID: 17660026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of mycophenolate mofetil in resistant membranous nephropathy.
    Miller G; Zimmerman R; Radhakrishnan J; Appel G
    Am J Kidney Dis; 2000 Aug; 36(2):250-6. PubMed ID: 10922302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
    Fujinaga S; Ohtomo Y; Hirano D; Nishizaki N; Someya T; Ohtsuka Y; Kaneko K; Shimizu T
    Clin Nephrol; 2009 Oct; 72(4):268-73. PubMed ID: 19825332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil treatment in primary glomerular disease: one-year follow-up in steroid dependent and resistant nephrotic syndrome.
    Tasanarong A; Thitiarchakul S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S218-27. PubMed ID: 17044475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
    Basu B; Babu BG; Mahapatra TK
    Clin Exp Nephrol; 2017 Feb; 21(1):143-151. PubMed ID: 27108294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome.
    Fujinaga S; Ohtomo Y; Umino D; Takemoto M; Shimizu T; Yamashiro Y; Kaneko K
    Pediatr Nephrol; 2007 Jan; 22(1):71-6. PubMed ID: 17086405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
    Orth T; Peters M; Schlaak JF; Krummenauer F; Wanitschke R; Mayet WJ; Galle PR; Neurath MF
    Am J Gastroenterol; 2000 May; 95(5):1201-7. PubMed ID: 10811328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome.
    Afzal K; Bagga A; Menon S; Hari P; Jordan SC
    Pediatr Nephrol; 2007 Dec; 22(12):2059-65. PubMed ID: 17938973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A prospective multicenter clinical control trial on treatment of refractory nephrotic syndrome with mycophenolate mofetil in children].
    Yi ZW; Wu XC; Xu H; Zhou LJ; Wu YB; Feng SP; Zhou JH; Yang Q; Zhu GH; Liu AM; Wei MJ; Yu L; Zeng ZF
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):575-8. PubMed ID: 18947472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.